(19)
(11) EP 3 638 209 A1

(12)

(43) Date of publication:
22.04.2020 Bulletin 2020/17

(21) Application number: 18818608.4

(22) Date of filing: 15.06.2018
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61K 47/06(2006.01)
A61K 47/34(2017.01)
A61K 47/54(2017.01)
A61K 47/00(2006.01)
A61K 47/10(2017.01)
A61K 47/50(2017.01)
A61K 49/00(2006.01)
(86) International application number:
PCT/US2018/037934
(87) International publication number:
WO 2018/232366 (20.12.2018 Gazette 2018/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.06.2017 US 201762520228 P

(71) Applicant: Dignity Health
Phoenix, Arizona 85013 (US)

(72) Inventors:
  • SIRIANNI, Rachael
    Sugar Land, Texas 77479 (US)
  • MEDINA, David Alexandro
    Phoenix, Arizona 85013 (US)
  • CHUNG, Eugene
    San Antonio, Texas 78218 (US)

(74) Representative: Hutter, Anton 
Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park
Guildford GU2 7RF
Guildford GU2 7RF (GB)

   


(54) NANOPARTICLE COMPOSITIONS, METHODS OF FABRICATION, AND USE FOR DRUG DELIVERY